Share Price and Basic Stock Data
Last Updated: January 6, 2026, 7:50 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Puravankara Ltd operates in the construction and contracting industry, focusing on real estate development. As of September 2023, the company’s share price stood at ₹242, with a market capitalization of ₹5,747 Cr. The company reported total sales of ₹1,236 Cr for FY 2023, reflecting a recovery from the pandemic’s impact, as sales had previously declined to ₹955 Cr in FY 2022. Quarterly sales figures showed an upward trend, with ₹574 Cr recorded in December 2023 and a projected rise to ₹920 Cr by March 2024. The total revenue for FY 2024 is anticipated to reach ₹2,185 Cr, suggesting a strong growth trajectory. Notably, the company’s operating profit margin (OPM) improved to 34% in December 2023, up from 19% in March 2023, indicating enhanced operational efficiency. However, despite positive revenue trends, the net profit for FY 2023 was negative at ₹292 Cr, highlighting ongoing challenges in profitability.
Profitability and Efficiency Metrics
Puravankara’s profitability metrics reveal significant fluctuations, with a net profit margin of -9.39% for FY 2025, down from 2.24% in FY 2024. The company recorded an operating profit of ₹230 Cr in FY 2023, but this declined to ₹291 Cr in FY 2025. The operating profit margin stood at 14% for FY 2025, a marked decrease from the 21% recorded in FY 2024. The interest coverage ratio (ICR) deteriorated to 0.66x in FY 2025, indicating that the company is struggling to meet interest obligations, compared to 1.24x in FY 2024. The return on equity (ROE) was reported at 10.0% but contrasts sharply with the return on capital employed (ROCE) of 6.04%, suggesting inefficiencies in capital utilization. With a cash conversion cycle of 84 days, the company has room for improvement in managing its working capital effectively, particularly as debtor days have risen to 157 days in FY 2023.
Balance Sheet Strength and Financial Ratios
Puravankara’s balance sheet reflects a challenging financial position, with total borrowings rising to ₹4,497 Cr as of September 2025, compared to ₹2,944 Cr in FY 2023. The debt-to-equity ratio stood at 2.48x for FY 2025, indicating high leverage, which could pose risks if cash flows do not stabilize. The company’s reserves decreased to ₹1,500 Cr by September 2025, down from ₹1,868 Cr in FY 2023, reflecting a declining buffer to absorb losses. The asset turnover ratio was reported at 0.15% for FY 2025, indicating lower efficiency in using assets to generate revenue. Furthermore, the price-to-book value ratio (P/BV) stood at 3.38x, suggesting that investor expectations may be high relative to the company’s tangible assets. The current ratio of 1.05x indicates that the company can cover its short-term liabilities, but a quick ratio of 0.18x raises concerns about liquidity, particularly in times of financial strain.
Shareholding Pattern and Investor Confidence
Puravankara’s shareholding structure is predominantly controlled by promoters, who hold 75% of the equity as of September 2025. Foreign institutional investors (FIIs) accounted for 17.23% of the shareholding, reflecting a steady interest from international investors, while domestic institutional investors (DIIs) constituted only 0.49%. The public shareholding stood at 7.28%, indicating limited retail investor participation. The number of shareholders decreased to 42,246 by September 2025, a decline from 45,955 in June 2025, which may reflect waning investor confidence amidst financial instability. The consistent promoter holding suggests a commitment to the company, but the low DII and public participation may indicate skepticism about the company’s future prospects. Overall, while the high promoter stake can be seen as a strength, the lack of broader investor support raises concerns regarding market sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Puravankara must navigate several risks, including high leverage and fluctuating profitability, which could hinder growth prospects. The increasing borrowings may limit financial flexibility and raise concerns over sustainability, especially given the declining profitability metrics. Additionally, the company’s cash conversion cycle and high debtor days need attention to improve working capital management. On the positive side, the upward trend in sales and operational improvements may provide a foundation for recovery if managed effectively. The company’s focus on enhancing operational efficiency could yield better returns in the future, particularly if it can stabilize its interest coverage and profitability metrics. Ultimately, while there are potential growth avenues, Puravankara must address its financial challenges to regain investor confidence and ensure long-term viability in the competitive real estate market.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Techindia Nirman Ltd | 20.1 Cr. | 14.0 | 30.3/13.8 | 7.54 | 0.00 % | 0.70 % | 7.32 % | 10.0 | |
| Tarmat Ltd | 123 Cr. | 49.0 | 80.9/45.0 | 40.1 | 72.9 | 0.00 % | 1.55 % | 0.92 % | 10.0 |
| Supreme Infrastructure India Ltd | 223 Cr. | 87.1 | 138/79.2 | 133 | 0.00 % | % | % | 10.0 | |
| SPML Infra Ltd – a Multi-sector Infrastructure Player | 1,477 Cr. | 193 | 323/136 | 30.1 | 112 | 0.00 % | 8.91 % | 7.78 % | 2.00 |
| SKIL Infrastructure Ltd | 25.6 Cr. | 1.18 | 4.86/1.05 | 2.87 | 8.93 | 0.00 % | 1.10 % | 4.76 % | 10.0 |
| Industry Average | 6,847.07 Cr | 215.36 | 44.21 | 108.04 | 0.04% | 6.53% | 9.16% | 7.10 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 239 | 392 | 389 | 323 | 368 | 574 | 920 | 658 | 496 | 318 | 542 | 524 | 644 |
| Expenses | 195 | 283 | 373 | 260 | 283 | 378 | 808 | 528 | 384 | 302 | 511 | 458 | 540 |
| Operating Profit | 45 | 110 | 16 | 63 | 85 | 196 | 112 | 130 | 112 | 16 | 30 | 67 | 104 |
| OPM % | 19% | 28% | 4% | 19% | 23% | 34% | 12% | 20% | 23% | 5% | 6% | 13% | 16% |
| Other Income | 13 | 18 | 91 | 13 | 13 | 22 | 27 | 18 | 32 | 17 | 22 | 14 | 19 |
| Interest | 76 | 94 | 102 | 98 | 105 | 105 | 127 | 119 | 141 | 143 | 152 | 161 | 169 |
| Depreciation | 4 | 5 | 4 | 5 | 6 | 7 | 10 | 7 | 8 | 8 | 11 | 10 | 11 |
| Profit before tax | -22 | 29 | 1 | -28 | -13 | 106 | 3 | 22 | -5 | -118 | -111 | -90 | -57 |
| Tax % | -22% | 22% | -2,093% | -36% | -13% | 27% | 352% | 31% | 257% | -22% | -21% | -24% | -24% |
| Net Profit | -17 | 23 | 27 | -18 | -11 | 78 | -7 | 15 | -17 | -93 | -88 | -69 | -43 |
| EPS in Rs | -0.72 | 0.95 | 1.12 | -0.75 | -0.47 | 3.29 | -0.28 | 0.64 | -0.71 | -3.90 | -3.62 | -2.85 | -1.76 |
Last Updated: December 29, 2025, 11:35 am
Below is a detailed analysis of the quarterly data for Puravankara Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 644.00 Cr.. The value appears strong and on an upward trend. It has increased from 524.00 Cr. (Jun 2025) to 644.00 Cr., marking an increase of 120.00 Cr..
- For Expenses, as of Sep 2025, the value is 540.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 458.00 Cr. (Jun 2025) to 540.00 Cr., marking an increase of 82.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 104.00 Cr.. The value appears strong and on an upward trend. It has increased from 67.00 Cr. (Jun 2025) to 104.00 Cr., marking an increase of 37.00 Cr..
- For OPM %, as of Sep 2025, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 13.00% (Jun 2025) to 16.00%, marking an increase of 3.00%.
- For Other Income, as of Sep 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Jun 2025) to 19.00 Cr., marking an increase of 5.00 Cr..
- For Interest, as of Sep 2025, the value is 169.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 161.00 Cr. (Jun 2025) to 169.00 Cr., marking an increase of 8.00 Cr..
- For Depreciation, as of Sep 2025, the value is 11.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10.00 Cr. (Jun 2025) to 11.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -57.00 Cr.. The value appears strong and on an upward trend. It has increased from -90.00 Cr. (Jun 2025) to -57.00 Cr., marking an increase of 33.00 Cr..
- For Tax %, as of Sep 2025, the value is -24.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded -24.00%.
- For Net Profit, as of Sep 2025, the value is -43.00 Cr.. The value appears strong and on an upward trend. It has increased from -69.00 Cr. (Jun 2025) to -43.00 Cr., marking an increase of 26.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is -1.76. The value appears strong and on an upward trend. It has increased from -2.85 (Jun 2025) to -1.76, marking an increase of 1.09.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:46 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,310 | 1,672 | 1,584 | 1,407 | 1,415 | 2,050 | 2,128 | 963 | 955 | 1,236 | 2,185 | 2,014 | 2,028 |
| Expenses | 835 | 1,287 | 1,244 | 998 | 1,110 | 1,612 | 1,681 | 681 | 746 | 1,006 | 1,730 | 1,723 | 1,811 |
| Operating Profit | 476 | 386 | 340 | 409 | 305 | 439 | 447 | 282 | 208 | 230 | 456 | 291 | 217 |
| OPM % | 36% | 23% | 21% | 29% | 22% | 21% | 21% | 29% | 22% | 19% | 21% | 14% | 11% |
| Other Income | 18 | 18 | 47 | 68 | 90 | 76 | 59 | 93 | 427 | 203 | 75 | 86 | 72 |
| Interest | 241 | 233 | 243 | 290 | 251 | 328 | 343 | 357 | 332 | 360 | 434 | 555 | 624 |
| Depreciation | 8 | 15 | 16 | 16 | 15 | 15 | 23 | 20 | 18 | 17 | 28 | 35 | 40 |
| Profit before tax | 244 | 156 | 128 | 171 | 129 | 172 | 140 | -2 | 286 | 55 | 68 | -212 | -376 |
| Tax % | 35% | 15% | 34% | 25% | 29% | 33% | 37% | 82% | 48% | -20% | 38% | -14% | |
| Net Profit | 160 | 133 | 83 | 129 | 91 | 114 | 88 | -4 | 148 | 67 | 42 | -183 | -292 |
| EPS in Rs | 6.75 | 5.60 | 3.49 | 5.44 | 3.85 | 4.82 | 3.73 | -0.17 | 6.22 | 2.80 | 1.78 | -7.59 | -12.13 |
| Dividend Payout % | 28% | 28% | 22% | 41% | 42% | 21% | 0% | 0% | 80% | 36% | 354% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -16.88% | -37.59% | 55.42% | -29.46% | 25.27% | -22.81% | -104.55% | 3800.00% | -54.73% | -37.31% | -535.71% |
| Change in YoY Net Profit Growth (%) | 0.00% | -20.72% | 93.02% | -84.88% | 54.73% | -48.08% | -81.74% | 3904.55% | -3854.73% | 17.42% | -498.40% |
Puravankara Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -1% |
| 3 Years: | 28% |
| TTM: | -25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -450% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 45% |
| 3 Years: | 39% |
| 1 Year: | -36% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 1% |
| 3 Years: | -1% |
| Last Year: | -10% |
Last Updated: September 5, 2025, 12:45 pm
Balance Sheet
Last Updated: December 4, 2025, 1:51 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 |
| Reserves | 2,055 | 2,142 | 2,165 | 2,248 | 2,275 | 1,738 | 1,795 | 1,777 | 1,923 | 1,868 | 1,765 | 1,612 | 1,500 |
| Borrowings | 1,697 | 1,793 | 2,172 | 2,067 | 2,379 | 2,895 | 2,670 | 2,835 | 2,627 | 2,944 | 3,325 | 4,332 | 4,497 |
| Other Liabilities | 869 | 1,109 | 1,090 | 1,814 | 2,011 | 3,973 | 3,487 | 3,697 | 3,955 | 5,125 | 6,518 | 8,169 | 9,219 |
| Total Liabilities | 4,739 | 5,163 | 5,546 | 6,247 | 6,783 | 8,725 | 8,071 | 8,429 | 8,623 | 10,055 | 11,727 | 14,232 | 15,335 |
| Fixed Assets | 92 | 112 | 88 | 114 | 125 | 128 | 122 | 111 | 96 | 107 | 163 | 232 | 233 |
| CWIP | 0 | 12 | 0 | 0 | 36 | 42 | 9 | 0 | 3 | 1 | 2 | 0 | 0 |
| Investments | 91 | 69 | 525 | 116 | 131 | 130 | 132 | 138 | 82 | 104 | 36 | 40 | 47 |
| Other Assets | 4,556 | 4,970 | 4,932 | 6,017 | 6,491 | 8,424 | 7,807 | 8,179 | 8,442 | 9,844 | 11,526 | 13,960 | 15,055 |
| Total Assets | 4,739 | 5,163 | 5,546 | 6,247 | 6,783 | 8,725 | 8,071 | 8,429 | 8,623 | 10,055 | 11,727 | 14,232 | 15,335 |
Below is a detailed analysis of the balance sheet data for Puravankara Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 119.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 119.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,500.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,612.00 Cr. (Mar 2025) to 1,500.00 Cr., marking a decrease of 112.00 Cr..
- For Borrowings, as of Sep 2025, the value is 4,497.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 4,332.00 Cr. (Mar 2025) to 4,497.00 Cr., marking an increase of 165.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 9,219.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8,169.00 Cr. (Mar 2025) to 9,219.00 Cr., marking an increase of 1,050.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 15,335.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14,232.00 Cr. (Mar 2025) to 15,335.00 Cr., marking an increase of 1,103.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 233.00 Cr.. The value appears strong and on an upward trend. It has increased from 232.00 Cr. (Mar 2025) to 233.00 Cr., marking an increase of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 47.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Mar 2025) to 47.00 Cr., marking an increase of 7.00 Cr..
- For Other Assets, as of Sep 2025, the value is 15,055.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,960.00 Cr. (Mar 2025) to 15,055.00 Cr., marking an increase of 1,095.00 Cr..
- For Total Assets, as of Sep 2025, the value is 15,335.00 Cr.. The value appears strong and on an upward trend. It has increased from 14,232.00 Cr. (Mar 2025) to 15,335.00 Cr., marking an increase of 1,103.00 Cr..
However, the Borrowings (4,497.00 Cr.) are higher than the Reserves (1,500.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 475.00 | 385.00 | 338.00 | 407.00 | 303.00 | 437.00 | 445.00 | 280.00 | 206.00 | 228.00 | 453.00 | 287.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 96 | 96 | 78 | 100 | 71 | 45 | 51 | 116 | 93 | 157 | 83 | 84 |
| Inventory Days | 1,328 | 1,718 | 6,990 | 3,052 | 2,438 | |||||||
| Days Payable | 145 | 155 | 658 | 211 | 216 | |||||||
| Cash Conversion Cycle | 96 | 1,279 | 1,641 | 100 | 6,403 | 2,886 | 2,273 | 116 | 93 | 157 | 83 | 84 |
| Working Capital Days | 425 | 372 | 536 | 502 | 410 | 180 | 153 | 488 | 580 | 322 | 32 | -27 |
| ROCE % | 13% | 9% | 9% | 10% | 8% | 10% | 10% | 8% | 13% | 7% | 10% | 6% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | -7.59 | 1.78 | 2.80 | 6.22 | -0.20 |
| Diluted EPS (Rs.) | -7.52 | 1.77 | 2.80 | 6.22 | -0.20 |
| Cash EPS (Rs.) | -6.50 | 3.25 | 2.21 | 7.18 | 0.76 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 72.98 | 79.67 | 84.05 | 86.38 | 80.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 72.98 | 79.67 | 84.05 | 86.38 | 80.49 |
| Revenue From Operations / Share (Rs.) | 84.91 | 92.14 | 52.11 | 40.26 | 40.51 |
| PBDIT / Share (Rs.) | 15.62 | 22.67 | 16.91 | 27.00 | 15.89 |
| PBIT / Share (Rs.) | 14.15 | 21.49 | 16.18 | 26.26 | 15.03 |
| PBT / Share (Rs.) | -9.21 | 3.18 | 1.02 | 12.27 | -0.01 |
| Net Profit / Share (Rs.) | -7.97 | 2.07 | 1.48 | 6.44 | -0.09 |
| NP After MI And SOA / Share (Rs.) | -7.58 | 1.78 | 2.80 | 6.22 | -0.19 |
| PBDIT Margin (%) | 18.39 | 24.60 | 32.44 | 67.08 | 39.22 |
| PBIT Margin (%) | 16.66 | 23.31 | 31.05 | 65.23 | 37.10 |
| PBT Margin (%) | -10.85 | 3.44 | 1.95 | 30.47 | -0.04 |
| Net Profit Margin (%) | -9.39 | 2.24 | 2.84 | 15.99 | -0.22 |
| NP After MI And SOA Margin (%) | -8.93 | 1.93 | 5.37 | 15.46 | -0.48 |
| Return on Networth / Equity (%) | -10.39 | 2.24 | 3.34 | 7.22 | -0.24 |
| Return on Capital Employeed (%) | 17.58 | 20.30 | 15.44 | 23.32 | 14.21 |
| Return On Assets (%) | -1.26 | 0.36 | 0.66 | 1.71 | -0.05 |
| Long Term Debt / Equity (X) | 0.06 | 0.30 | 0.23 | 0.28 | 0.28 |
| Total Debt / Equity (X) | 2.48 | 1.74 | 1.47 | 1.28 | 0.74 |
| Asset Turnover Ratio (%) | 0.15 | 0.20 | 0.13 | 0.10 | 0.08 |
| Current Ratio (X) | 1.05 | 1.12 | 1.19 | 1.30 | 1.24 |
| Quick Ratio (X) | 0.18 | 0.20 | 0.18 | 0.15 | 0.16 |
| Inventory Turnover Ratio (X) | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 353.52 | 178.36 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 212.48 | 141.82 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | -253.52 | -78.36 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | -112.48 | -41.82 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 0.66 | 1.24 | 1.11 | 1.93 | 1.06 |
| Interest Coverage Ratio (Post Tax) (X) | 0.65 | 1.11 | 1.10 | 1.46 | 0.99 |
| Enterprise Value (Cr.) | 9425.39 | 7334.08 | 4121.77 | 4843.19 | 2925.63 |
| EV / Net Operating Revenue (X) | 4.68 | 3.36 | 3.34 | 5.07 | 3.05 |
| EV / EBITDA (X) | 25.44 | 13.64 | 10.28 | 7.56 | 7.76 |
| MarketCap / Net Operating Revenue (X) | 2.91 | 2.28 | 1.25 | 2.65 | 1.74 |
| Retention Ratios (%) | 0.00 | -253.52 | -78.36 | 0.00 | 0.00 |
| Price / BV (X) | 3.38 | 2.64 | 0.77 | 1.24 | 0.87 |
| Price / Net Operating Revenue (X) | 2.91 | 2.28 | 1.25 | 2.65 | 1.74 |
| EarningsYield | -0.03 | 0.01 | 0.04 | 0.05 | 0.00 |
After reviewing the key financial ratios for Puravankara Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -7.59. This value is below the healthy minimum of 5. It has decreased from 1.78 (Mar 24) to -7.59, marking a decrease of 9.37.
- For Diluted EPS (Rs.), as of Mar 25, the value is -7.52. This value is below the healthy minimum of 5. It has decreased from 1.77 (Mar 24) to -7.52, marking a decrease of 9.29.
- For Cash EPS (Rs.), as of Mar 25, the value is -6.50. This value is below the healthy minimum of 3. It has decreased from 3.25 (Mar 24) to -6.50, marking a decrease of 9.75.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 72.98. It has decreased from 79.67 (Mar 24) to 72.98, marking a decrease of 6.69.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 72.98. It has decreased from 79.67 (Mar 24) to 72.98, marking a decrease of 6.69.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 84.91. It has decreased from 92.14 (Mar 24) to 84.91, marking a decrease of 7.23.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 15.62. This value is within the healthy range. It has decreased from 22.67 (Mar 24) to 15.62, marking a decrease of 7.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.15. This value is within the healthy range. It has decreased from 21.49 (Mar 24) to 14.15, marking a decrease of 7.34.
- For PBT / Share (Rs.), as of Mar 25, the value is -9.21. This value is below the healthy minimum of 0. It has decreased from 3.18 (Mar 24) to -9.21, marking a decrease of 12.39.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -7.97. This value is below the healthy minimum of 2. It has decreased from 2.07 (Mar 24) to -7.97, marking a decrease of 10.04.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -7.58. This value is below the healthy minimum of 2. It has decreased from 1.78 (Mar 24) to -7.58, marking a decrease of 9.36.
- For PBDIT Margin (%), as of Mar 25, the value is 18.39. This value is within the healthy range. It has decreased from 24.60 (Mar 24) to 18.39, marking a decrease of 6.21.
- For PBIT Margin (%), as of Mar 25, the value is 16.66. This value is within the healthy range. It has decreased from 23.31 (Mar 24) to 16.66, marking a decrease of 6.65.
- For PBT Margin (%), as of Mar 25, the value is -10.85. This value is below the healthy minimum of 10. It has decreased from 3.44 (Mar 24) to -10.85, marking a decrease of 14.29.
- For Net Profit Margin (%), as of Mar 25, the value is -9.39. This value is below the healthy minimum of 5. It has decreased from 2.24 (Mar 24) to -9.39, marking a decrease of 11.63.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -8.93. This value is below the healthy minimum of 8. It has decreased from 1.93 (Mar 24) to -8.93, marking a decrease of 10.86.
- For Return on Networth / Equity (%), as of Mar 25, the value is -10.39. This value is below the healthy minimum of 15. It has decreased from 2.24 (Mar 24) to -10.39, marking a decrease of 12.63.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.58. This value is within the healthy range. It has decreased from 20.30 (Mar 24) to 17.58, marking a decrease of 2.72.
- For Return On Assets (%), as of Mar 25, the value is -1.26. This value is below the healthy minimum of 5. It has decreased from 0.36 (Mar 24) to -1.26, marking a decrease of 1.62.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.30 (Mar 24) to 0.06, marking a decrease of 0.24.
- For Total Debt / Equity (X), as of Mar 25, the value is 2.48. This value exceeds the healthy maximum of 1. It has increased from 1.74 (Mar 24) to 2.48, marking an increase of 0.74.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.15. It has decreased from 0.20 (Mar 24) to 0.15, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.05. This value is below the healthy minimum of 1.5. It has decreased from 1.12 (Mar 24) to 1.05, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 1. It has decreased from 0.20 (Mar 24) to 0.18, marking a decrease of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.21, marking an increase of 0.21.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 353.52 (Mar 24) to 0.00, marking a decrease of 353.52.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 212.48 (Mar 24) to 0.00, marking a decrease of 212.48.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has increased from -253.52 (Mar 24) to 0.00, marking an increase of 253.52.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has increased from -112.48 (Mar 24) to 0.00, marking an increase of 112.48.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 3. It has decreased from 1.24 (Mar 24) to 0.66, marking a decrease of 0.58.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 3. It has decreased from 1.11 (Mar 24) to 0.65, marking a decrease of 0.46.
- For Enterprise Value (Cr.), as of Mar 25, the value is 9,425.39. It has increased from 7,334.08 (Mar 24) to 9,425.39, marking an increase of 2,091.31.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.68. This value exceeds the healthy maximum of 3. It has increased from 3.36 (Mar 24) to 4.68, marking an increase of 1.32.
- For EV / EBITDA (X), as of Mar 25, the value is 25.44. This value exceeds the healthy maximum of 15. It has increased from 13.64 (Mar 24) to 25.44, marking an increase of 11.80.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.91. This value is within the healthy range. It has increased from 2.28 (Mar 24) to 2.91, marking an increase of 0.63.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has increased from -253.52 (Mar 24) to 0.00, marking an increase of 253.52.
- For Price / BV (X), as of Mar 25, the value is 3.38. This value exceeds the healthy maximum of 3. It has increased from 2.64 (Mar 24) to 3.38, marking an increase of 0.74.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.91. This value is within the healthy range. It has increased from 2.28 (Mar 24) to 2.91, marking an increase of 0.63.
- For EarningsYield, as of Mar 25, the value is -0.03. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to -0.03, marking a decrease of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Puravankara Ltd:
- Net Profit Margin: -9.39%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.58% (Industry Average ROCE: 6.53%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -10.39% (Industry Average ROE: 9.16%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.65
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.18
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 44.21)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.48
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -9.39%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Realty | No.130/1, Ulsoor Road, Bengaluru Karnataka 560042 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ravi Puravankara | Chairman |
| Mr. Ashish Ravi Puravankara | Managing Director |
| Ms. Amanda Joy Puravankara | Whole Time Director |
| Mr. Anup Shah Sanmukh | Independent Director |
| Prof. Shailaja Jha | Independent Director |
| Mr. K G Krishnamurthy | Independent Director |
FAQ
What is the intrinsic value of Puravankara Ltd?
Puravankara Ltd's intrinsic value (as of 07 January 2026) is ₹83.60 which is 65.45% lower the current market price of ₹242.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹5,747 Cr. market cap, FY2025-2026 high/low of ₹390/205, reserves of ₹1,500 Cr, and liabilities of ₹15,335 Cr.
What is the Market Cap of Puravankara Ltd?
The Market Cap of Puravankara Ltd is 5,747 Cr..
What is the current Stock Price of Puravankara Ltd as on 07 January 2026?
The current stock price of Puravankara Ltd as on 07 January 2026 is ₹242.
What is the High / Low of Puravankara Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Puravankara Ltd stocks is ₹390/205.
What is the Stock P/E of Puravankara Ltd?
The Stock P/E of Puravankara Ltd is .
What is the Book Value of Puravankara Ltd?
The Book Value of Puravankara Ltd is 68.3.
What is the Dividend Yield of Puravankara Ltd?
The Dividend Yield of Puravankara Ltd is 0.00 %.
What is the ROCE of Puravankara Ltd?
The ROCE of Puravankara Ltd is 6.04 %.
What is the ROE of Puravankara Ltd?
The ROE of Puravankara Ltd is 10.0 %.
What is the Face Value of Puravankara Ltd?
The Face Value of Puravankara Ltd is 5.00.